"Alternative" endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?

Advanced Drug Delivery Reviews

Volumn 59, Issue 8, 2007, Pages 798-809

  Medina Kauwe, L K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; PATHOGENS; PROTEINS;

CAVEOLAR UPTAKE; DELIVERY AGENTS; ENDOCYTOSIS; RETROGRADE TRANSPORT;

DRUG DELIVERY;

ABRIN; BACTERIAL TOXIN; CELL PROTEIN; CHOLERA TOXIN; PLANT TOXIN; PRION PROTEIN; PSEUDOMONAS EXOTOXIN; RICIN; SHIGA TOXIN;

BRUCELLA; BRUCELLOSIS; CAVEOLA; CELL DEATH; CELL SURFACE; CYTOSOL; DNA VECTOR; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENDOCYTOSIS; ENDOSOME; EXOSOME; GENE EXPRESSION; GENE THERAPY; HUMAN; INTRACELLULAR TRANSPORT; LYSOSOME; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SIMIAN VIRUS 40; SURVIVAL RATE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BACTERIAL TOXINS; BIOLOGICAL TRANSPORT; CAVEOLAE; CLATHRIN; CLATHRIN-COATED VESICLES; COATED PITS, CELL-MEMBRANE; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOSOMES; GOLGI APPARATUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PRIONS; TOXINS, BIOLOGICAL; TRANS-GOLGI NETWORK; VESICULAR TRANSPORT PROTEINS;

EID: 34548231783     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2007.06.009     Document Type: Review

References (151)

1. Medina-Kauwe L.K., Xie J., and Hamm-Alvarez S. Intracellular trafficking of nonviral vectors. Gene Ther. 12 (2005) 1734-1751
2. Khalil I.A., Kogure K., Akita H., and Harashima H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol. Rev. 58 (2006) 32-45
3. Mukherjee S., Ghosh R.N., and Maxfield F.R. Endocytosis. Physiol. Rev. 77 (1997) 759-803
4. Sandvig K., and van Deurs B. Delivery into cells: lessons learned from plant and bacterial toxins. Gene Ther. 12 (2005) 865-872
5. Johannes L., and Decaudin D. Protein toxins: intracellular trafficking for targeted therapy. Gene Ther. 12 (2005) 1360-1368
6. Pelkmans L. Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses. Biochim. Biophys Acta. 1746 (2005) 295-304 (Electronic publication 2005 Jul 2005)
7. Celli J. Surviving inside a macrophage: the many ways of Brucella. Res. Microbiol. 157 (2006) 93-98 (Electronic publication 2005 Nov 2009)
8. Fevrier B., Vilette D., Laude H., and Raposo G. Exosomes: a bubble ride for prions?. Traffic. 6 (2005) 10-17
9. Porto-Carreiro I., Fevrier B., Paquet S., Vilette D., and Raposo G. Prions and exosomes: from PrPc trafficking to PrPsc propagation. Blood Cells Mol. Dis. 35 (2005) 143-148
10. Wagner E. Application of membrane-active peptides for nonviral gene delivery. Adv. Drug Deliv. Rev. 38 (1999) 279-289
11. Lukacs G.L., Haggie P., Seksek O., Lechardeur D., Freedman N., and Verkman A.S. Size-dependent DNA mobility in cytoplasm and nucleus. J. Biol. Chem. 275 (2000) 1625-1629
12. 2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids. J. Gene Med. 3 (2001) 153-164
13. Lord J.M., and Roberts L.M. Toxin entry: retrograde transport through the secretory pathway. J. Cell. Biol. 140 (1998) 733-736
14. Sandvig K., and van Deurs B. Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives. EMBO J. 19 (2000) 5943-5950
15. Endo Y., and Tsurugi K. RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J. Biol. Chem. 262 (1987) 8128-8130
16. Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara T., and Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur. J. Biochem. 171 (1988) 45-50
17. Moss J., and Vaughan M. Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor. J. Biol. Chem. 252 (1977) 2455-2457
18. Kaper J.B., Morris Jr. J.G., and Levine M.M. Cholera. Clin. Microbiol. Rev. 8 (1995) 48-86
19. Iglewski B.H., and Kabat D. NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin. Proc. Natl. Acad. Sci. U. S. A. 72 (1975) 2284-2288
20. Waddell T., Cohen A., and Lingwood C.A. Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 7898-7901
21. Jacewicz M., Clausen H., Nudelman E., Donohue-Rolfe A., and Keusch G.T. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J. Exp. Med. 163 (1986) 1391-1404
22. Lindberg A.A., Brown J.E., Stromberg N., Westling-Ryd M., Schultz J.E., and Karlsson K.A. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J. Biol. Chem. 262 (1987) 1779-1785
23. Holmgren J., Lonnroth I., and Svennerholm L. Tissue receptor for cholera exotoxin: postulated structure from studies with GM1 ganglioside and related glycolipids. Infect. Immun. 8 (1973) 208-214
24. Holmgren J., Lonnroth I., and Svennerholm L. Fixation and inactivation of cholera toxin by GM1 ganglioside. Scand. J. Infect. Dis. 5 (1973) 77-78
25. Kounnas M.Z., Morris R.E., Thompson M.R., FitzGerald D.J., Strickland D.K., and Saelinger C.B. The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J. Biol. Chem. 267 (1992) 12420-12423
26. Olsnes S., and Pihl A. Toxic lectins and related proteins. In: van Heyningen S. (Ed). Molecular Action of Toxins and Viruses (1982), Elsevier, Amsterdam 51-105
27. Smith D.C., Sillence D.J., Falguieres T., Jarvis R.M., Johannes L., Lord J.M., Platt F.M., and Roberts L.M. The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol. Biol. Cell. 17 (2006) 1375-1387 (Electronic publication 2005 Dec 1328)
28. Smith D.C., Spooner R.A., Watson P.D., Murray J.L., Hodge T.W., Amessou M., Johannes L., Lord J.M., and Roberts L.M. Internalized Pseudomonas exotoxin A can exploit multiple pathways to reach the endoplasmic reticulum. Traffic 7 (2006) 379-393
29. Lombardi D., Soldati T., Riederer M.A., Goda Y., Zerial M., and Pfeffer S.R. Rab9 functions in transport between late endosomes and the trans Golgi network. EMBO J. 12 (1993) 677-682
30. Sandvig K., Grimmer S., Lauvrak S.U., Torgersen M.L., Skretting G., van Deurs B., and Iversen T.G. Pathways followed by ricin and Shiga toxin into cells. Histochem. Cell Biol. 117 (2002) 131-141 (Electronic publication 2001 Nov 2020)
31. Bonifacino J.S., and Rojas R. Retrograde transport from endosomes to the trans-Golgi network. Nat. Rev., Mol. Cell Biol. 7 (2006) 568-579
32. Lewis M.J., Nichols B.J., Prescianotto-Baschong C., Riezman H., and Pelham H.R. Specific retrieval of the exocytic SNARE Snc1p from early yeast endosomes. Mol. Biol. Cell 11 (2000) 23-38
33. Miesenbock G., and Rothman J.E. The capacity to retrieve escaped ER proteins extends to the trans-most cisterna of the Golgi stack. J. Cell Biol. 129 (1995) 309-319
34. Cosson P., and Letourneur F. Coatomer (COPI)-coated vesicles: role in intracellular transport and protein sorting. Curr. Opin. Cell Biol. 9 (1997) 484-487
35. Letourneur F., Gaynor E.C., Hennecke S., Demolliere C., Duden R., Emr S.D., Riezman H., and Cosson P. Coatomer is essential for retrieval of dilysine-tagged proteins to the endoplasmic reticulum. Cell 79 (1994) 1199-1207
36. Chaudhary V.K., Jinno Y., FitzGerald D., and Pastan I. Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 308-312
37. Jackson M.E., Simpson J.C., Girod A., Pepperkok R., Roberts L.M., and Lord J.M. The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum. J. Cell Sci. 112 (1999) 467-475
38. Kreitman R.J., and Pastan I. Importance of the glutamate residue of KDEL in increasing the cytotoxicity of Pseudomonas exotoxin derivatives and for increased binding to the KDEL receptor. Biochem. J. 307 (1995) 29-37
39. Seetharam S., Chaudhary V.K., FitzGerald D., and Pastan I. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL. J. Biol. Chem. 266 (1991) 17376-17381
40. Mallard F., Tang B.L., Galli T., Tenza D., Saint-Pol A., Yue X., Antony C., Hong W., Goud B., and Johannes L. Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform. J. Cell Biol. 156 (2002) 653-664 (Electronic publication 2002 Feb 2011)
41. Girod A., Storrie B., Simpson J.C., Johannes L., Goud B., Roberts L.M., Lord J.M., Nilsson T., and Pepperkok R. Evidence for a COP-I-independent transport route from the Golgi complex to the endoplasmic reticulum. Nat. Cell Biol. 1 (1999) 423-430
42. White J., Johannes L., Mallard F., Girod A., Grill S., Reinsch S., Keller P., Tzschaschel B., Echard A., Goud B., and Stelzer E.H. Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells. J. Cell Biol. 147 (1999) 743-760
43. Monier S., Jollivet F., Janoueix-Lerosey I., Johannes L., and Goud B. Characterization of novel Rab6-interacting proteins involved in endosome-to-TGN transport. Traffic 3 (2002) 289-297
44. Feng Y., Jadhav A.P., Rodighiero C., Fujinaga Y., Kirchhausen T., and Lencer W.I. Retrograde transport of cholera toxin from the plasma membrane to the endoplasmic reticulum requires the trans-Golgi network but not the Golgi apparatus in Exo2-treated cells. EMBO Rep. 5 (2004) 596-601 (Electronic publication 2004 May 2021)
45. Day P.J., Owens S.R., Wesche J., Olsnes S., Roberts L.M., and Lord J.M. An interaction between ricin and calreticulin that may have implications for toxin trafficking. J. Biol. Chem. 276 (2001) 7202-7208 (Electronic publication 2000 Dec 7211)
46. Chen A., AbuJarour R.J., and Draper R.K. Evidence that the transport of ricin to the cytoplasm is independent of both Rab6A and COPI. J. Cell Sci. 116 (2003) 3503-3510 (Electronic publication 2003 Jul 3515)
47. Clemons Jr. W.M., Menetret J.F., Akey C.W., and Rapoport T.A. Structural insight into the protein translocation channel. Curr. Opin. Struct. Biol. 14 (2004) 390-396
48. Van den Berg B., Clemons Jr. W.M., Collinson I., Modis Y., Hartmann E., Harrison S.C., and Rapoport T.A. X-ray structure of a protein-conducting channel. Nature 427 (2004) 36-44 (Electronic publication 2003 Dec 2003)
49. Hazes B., and Read R.J. Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. Biochemistry 36 (1997) 11051-11054
50. Fisher K.J., and Wilson J.M. The transmembrane domain of diphtheria toxin improves molecular conjugate gene transfer. Biochem. J. 321 (1997) 49-58
51. Madshus I.H., Olsnes S., and Stenmark H. Membrane translocation of diphtheria toxin carrying passenger protein domains. Infect. Immun. 60 (1992) 3296-3302
52. Stenmark H., Moskaug J.O., Madshus I.H., Sandvig K., and Olsnes S. Peptides fused to the amino-terminal end of diphtheria toxin are translocated to the cytosol. J. Cell Biol. 113 (1991) 1025-1032
53. Fominaya J., Uherek C., and Wels W. A chimeric fusion protein containing transforming growth factor-α mediates gene transfer via binding to the EGF receptor. Gene Ther. 5 (1998) 521-530
54. Fominaya J., and Wels W. Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system. J. Biol. Chem. 271 (1996) 10560-10568
55. Barrett L.B., Berry M., Ying W.B., Hodgkin M.N., Seymour L.W., Gonzalez A.M., Read M.L., Baird A., and Logan A. CTb targeted non-viral cDNA delivery enhances transgene expression in neurons. J. Gene Med. 6 (2004) 429-438
56. Barrett L.B., Logan A., Berry M., Ying W., Gonzalez A.M., Baird A., and Seymour L.W. Targeted transfection of neuronal cells using a poly(d-lysine)-cholera-toxin b chain conjugate. Biochem. Soc. Trans. 27 (1999) 851-857
57. Gaur R., Gupta P.K., Goyal A., Wels W., and Singh Y. Delivery of nucleic acid into mammalian cells by anthrax toxin. Biochem. Biophys. Res. Commun. 297 (2002) 1121-1127
58. Facchini L.M., and Lingwood C.A. A verotoxin 1 B subunit-lambda CRO chimeric protein specifically binds both DNA and globotriaosylceramide (Gb(3)) to effect nuclear targeting of exogenous DNA in Gb(3) positive cells. Exp. Cell Res. 269 (2001) 117-129
59. Smith D.C., Lord J.M., Roberts L.M., Tartour E., and Johannes L. 1st class ticket to class I: protein toxins as pathfinders for antigen presentation. Traffic 3 (2002) 697-704
60. Cabiaux V. pH-sensitive toxins: interactions with membrane bilayers and application to drug delivery. Adv. Drug Deliv. Rev. 56 (2004) 987-997
61. Donnelly J.J., Ulmer J.B., Hawe L.A., Friedman A., Shi X.P., Leander K.R., Shiver J.W., Oliff A.I., Martinez D., Montgomery D., and Liu M.A. Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 3530-3534
62. Haicheur N., Bismuth E., Bosset S., Adotevi O., Warnier G., Lacabanne V., Regnault A., Desaymard C., Amigorena S., Ricciardi-Castagnoli P., Goud B., Fridman W.H., Johannes L., and Tartour E. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J. Immunol. 165 (2000) 3301-3308
63. Lasmezas C.I. Putative functions of PrP(C). Br. Med. Bull. 66 (2003) 61-70
64. Martins V.R., Linden R., Prado M.A., Walz R., Sakamoto A.C., Izquierdo I., and Brentani R.R. Cellular prion protein: on the road for functions. FEBS Lett. 512 (2002) 25-28
65. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13363-13383
66. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24 (2001) 519-550
67. Tuite M.F., and Koloteva-Levin N. Propagating prions in fungi and mammals. Mol. Cell 14 (2004) 541-552
68. Aguzzi A. Prions and the immune system: a journey through gut, spleen, and nerves. Adv. Immunol. 81 (2003) 123-171
69. Haik S., Faucheux B.A., and Hauw J.J. Brain targeting through the autonomous nervous system: lessons from prion diseases. Trends Mol. Med. 10 (2004) 107-112
70. Mabbott N.A., and Bruce M.E. The immunobiology of TSE diseases. J. Gen. Virol. 82 (2001) 2307-2318
71. Aucouturier P., and Carnaud C. The immune system and prion diseases: a relationship of complicity and blindness. J. Leukoc. Biol. 72 (2002) 1075-1083
72. Fevrier B., Vilette D., Archer F., Loew D., Faigle W., Vidal M., Laude H., and Raposo G. Cells release prions in association with exosomes. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9683-9688 (Electronic publication 2004 Jun 9621)
73. Campana V., Sarnataro D., and Zurzolo C. The highways and byways of prion protein trafficking. Trends Cell Biol. 15 (2005) 102-111
74. Harris D.A. Trafficking, turnover and membrane topology of PrP. Br. Med. Bull. 66 (2003) 71-85
75. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
76. Peters P.J., Mironov Jr. A., Peretz D., van Donselaar E., Leclerc E., Erpel S., DeArmond S.J., Burton D.R., Williamson R.A., Vey M., and Prusiner S.B. Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J. Cell Biol. 162 (2003) 703-717
77. Shyng S.L., Heuser J.E., and Harris D.A. A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J. Cell Biol. 125 (1994) 1239-1250
78. Mironov Jr. A., Latawiec D., Wille H., Bouzamondo-Bernstein E., Legname G., Williamson R.A., Burton D., DeArmond S.J., Prusiner S.B., and Peters P.J. Cytosolic prion protein in neurons. J. Neurosci. 23 (2003) 7183-7193
79. Trowbridge I.S., Collawn J.F., and Hopkins C.R. Signal-dependent membrane protein trafficking in the endocytic pathway. Annu. Rev. Cell Biol. 9 (1993) 129-161
80. van Deurs B., Holm P.K., Kayser L., Sandvig K., and Hansen S.H. Multivesicular bodies in HEp-2 cells are maturing endosomes. Eur. J. Cell Biol. 61 (1993) 208-224
81. Babst M. A protein's final ESCRT. Traffic 6 (2005) 2-9
82. van Niel G., Porto-Carreiro I., Simoes S., and Raposo G. Exosomes: a common pathway for a specialized function. J. Biochem. (Tokyo) 140 (2006) 13-21
83. Baron G.S., Wehrly K., Dorward D.W., Chesebro B., and Caughey B. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J. 21 (2002) 1031-1040
84. Borchelt D.R., Taraboulos A., and Prusiner S.B. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 267 (1992) 16188-16199
85. Caughey B., and Raymond G.J. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J. Biol. Chem. 266 (1991) 18217-18223
86. van Dillen I.J., Mulder N.H., Vaalburg W., de Vries E.F., and Hospers G.A. Influence of the bystander effect on HSV-tk/GCV gene therapy. A review. Curr. Gene Ther. 2 (2002) 307-322
87. Liu C.S., Kong B., Xia H.H., Ellem K.A., and Wei M.Q. VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death. J. Gene Med. 3 (2001) 145-152
88. Aints A., Guven H., Gahrton G., Smith C.I., and Dilber M.S. Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting. Gene Ther. 8 (2001) 1051-1056
89. Elliott G., and O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88 (1997) 223-233
90. Yamada E. The fine structure of the gall bladder epithelium of the mouse. J. Biophys. Biochem. Cytol. 1 (1955) 445-458
91. Rothberg K.G., Heuser J.E., Donzell W.C., Ying Y.S., Glenney J.R., and Anderson R.G. Caveolin, a protein component of caveolae membrane coats. Cell 68 (1992) 673-682
92. Kurzchalia T.V., Dupree P., Parton R.G., Kellner R., Virta H., Lehnert M., and Simons K. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J. Cell Biol. 118 (1992) 1003-1014
93. Dietzen D.J., Hastings W.R., and Lublin D.M. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J. Biol. Chem. 270 (1995) 6838-6842
94. Murata M., Peranen J., Schreiner R., Wieland F., Kurzchalia T.V., and Simons K. VIP21/caveolin is a cholesterol-binding protein. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 10339-10343
95. Cohen A.W., Hnasko R., Schubert W., and Lisanti M.P. Role of caveolae and caveolins in health and disease. Physiol. Rev. 84 (2004) 1341-1379
96. Richterova Z., Liebl D., Horak M., Palkova Z., Stokrova J., Hozak P., Korb J., and Forstova J. Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei. J. Virol. 75 (2001) 10880-10891
97. Pietiainen V., Marjomaki V., Upla P., Pelkmans L., Helenius A., and Hyypia T. Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events. Mol. Biol. Cell 15 (2004) 4911-4925 (Electronic publication 2004 Sep 4918)
98. Marjomaki V., Pietiainen V., Matilainen H., Upla P., Ivaska J., Nissinen L., Reunanen H., Huttunen P., Hyypia T., and Heino J. Internalization of echovirus 1 in caveolae. J. Virol. 76 (2002) 1856-1865
99. Nunes-Correia I., Eulalio A., Nir S., and Pedroso de Lima M.C. Caveolae as an additional route for influenza virus endocytosis in MDCK cells. Cell Mol. Biol. Lett. 9 (2004) 47-60
100. Nomura R., Kiyota A., Suzaki E., Kataoka K., Ohe Y., Miyamoto K., Senda T., and Fujimoto T. Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae. J. Virol. 78 (2004) 8701-8708
101. Pelkmans L., Kartenbeck J., and Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3 (2001) 473-483
102. Damm E.M., Pelkmans L., Kartenbeck J., Mezzacasa A., Kurzchalia T., and Helenius A. Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 168 (2005) 477-488 (Electronic publication 2005 Jan 2024)
103. Anderson H.A., Chen Y., and Norkin L.C. Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol. Biol. Cell. 7 (1996) 1825-1834
104. Pelkmans L., Puntener D., and Helenius A. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296 (2002) 535-539
105. Tsai B., Gilbert J.M., Stehle T., Lencer W., Benjamin T.L., and Rapoport T.A. Gangliosides are receptors for murine polyoma virus and SV40. EMBO J. 22 (2003) 4346-4355
106. Bernacchi S., Mueller G., Langowski J., and Waldeck W. Characterization of simian virus 40 on its infectious entry pathway in cells using fluorescence correlation spectroscopy. Biochem. Soc. Trans. 32 (2004) 746-749
107. Anderson H.A., Chen Y., and Norkin L.C. MHC class I molecules are enriched in caveolae but do not enter with simian virus 40. J. Gen. Virol. 79 (1998) 1469-1477
108. Stang E., Kartenbeck J., and Parton R.G. Major histocompatibility complex class I molecules mediate association of SV40 with caveolae. Mol. Biol. Cell 8 (1997) 47-57
109. Dangoria N.S., Breau W.C., Anderson H.A., Cishek D.M., and Norkin L.C. Extracellular simian virus 40 induces an ERK/MAP kinase-independent signalling pathway that activates primary response genes and promotes virus entry. J. Gen. Virol. 77 (1996) 2173-2182
110. Mundy D.I., Machleidt T., Ying Y.S., Anderson R.G., and Bloom G.S. Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton. J. Cell Sci. 115 (2002) 4327-4339
111. Pelkmans L., Burli T., Zerial M., and Helenius A. Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 118 (2004) 767-780
112. Puri V., Watanabe R., Singh R.D., Dominguez M., Brown J.C., Wheatley C.L., Marks D.L., and Pagano R.E. Clathrin-dependent and -independent internalization of plasma membrane sphingolipids initiates two Golgi targeting pathways. J. Cell Biol. 154 (2001) 535-547 (Electronic publication 2001 Jul 2030)
113. Nichols B.J. A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex. Nat. Cell Biol. 4 (2002) 374-378
114. Di Guglielmo G.M., Le Roy C., Goodfellow A.F., and Wrana J.L. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat. Cell Biol. 5 (2003) 410-421
115. Nabi I.R., and Le P.U. Caveolae/raft-dependent endocytosis. J. Cell Biol. 161 (2003) 673-677
116. Richards A.A., Stang E., Pepperkok R., and Parton R.G. Inhibitors of COP-mediated transport and cholera toxin action inhibit simian virus 40 infection. Mol. Biol Cell. 13 (2002) 1750-1764
117. Kasamatsu H., and Nakanishi A. How do animal DNA viruses get to the nucleus?. Annu. Rev. Microbiol. 52 (1998) 627-686
118. Lipardi C., Mora R., Colomer V., Paladino S., Nitsch L., Rodriguez-Boulan E., and Zurzolo C. Caveolin transfection results in caveolae formation but not apical sorting of glycosylphosphatidylinositol (GPI)-anchored proteins in epithelial cells. J. Cell Biol. 140 (1998) 617-626
119. Minshall R.D., Tiruppathi C., Vogel S.M., Niles W.D., Gilchrist A., Hamm H.E., and Malik A.B. Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway. J. Cell Biol. 150 (2000) 1057-1070
120. Thomsen P., Roepstorff K., Stahlhut M., and van Deurs B. Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol Biol. Cell 13 (2002) 238-250
121. Oh P., Borgstrom P., Witkiewicz H., Li Y., Borgstrom B.J., Chrastina A., Iwata K., Zinn K.R., Baldwin R., Testa J.E., and Schnitzer J.E. Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat. Biotechnol. 25 (2007) 327-337 (Electronic publication 2007 Mar 2004)
122. Rentsendorj A., Xie J., MacVeigh M., Agadjanian H., Bass S., Kim D.H., Rossi J., Hamm-Alvarez S.F., and Medina-Kauwe L.K. Typical and atypical trafficking pathways of Ad5 penton base recombinant protein: implications for gene transfer. Gene Ther. 13 (2006) 821-836
123. Huth S., Lausier J., Gersting S.W., Rudolph C., Plank C., Welsch U., and Rosenecker J. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J.Gene Med. 6 (2004) 923-936
124. Rejman J., Oberle V., Zuhorn I.S., and Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 377 (2004) 159-169
125. van der Aa M.A., Huth U.S., Hafele S.Y., Schubert R., Oosting R.S., Mastrobattista E., Hennink W.E., Peschka-Suss R., Koning G.A., and Crommelin D.J. Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells. Pharm. Res. 24 (2007) 24
126. Goncalves C., Mennesson E., Fuchs R., Gorvel J.P., Midoux P., and Pichon C. Macropinocytosis of polyplexes and recycling of plasmid via the clathrin-dependent pathway impair the transfection efficiency of human hepatocarcinoma cells. Mol. Ther. 10 (2004) 373-385
127. Pizarro-Cerda J., Moreno E., Desjardins M., and Gorvel J.P. When intracellular pathogens invade the frontiers of cell biology and immunology. Histol. Histopathol. 12 (1997) 1027-1038
128. Meresse S., Steele-Mortimer O., Moreno E., Desjardins M., Finlay B., and Gorvel J.P. Controlling the maturation of pathogen-containing vacuoles: a matter of life and death. Nat. Cell Biol. 1 (1999) E183-E188
129. Celli J., de Chastellier C., Franchini D.M., Pizarro-Cerda J., Moreno E., and Gorvel J.P. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J. Exp. Med. 198 (2003) 545-556
130. Gorvel J.P., and Moreno E. Brucella intracellular life: from invasion to intracellular replication. Vet. Microbiol. 90 (2002) 281-297
131. Al-Younes H.M., Rudel T., and Meyer T.F. Characterization and intracellular trafficking pattern of vacuoles containing Chlamydia pneumoniae in human epithelial cells. Cell Microbiol. 1 (1999) 237-247
132. Watarai M., Kim S., Erdenebaatar J., Makino S., Horiuchi M., Shirahata T., Sakaguchi S., and Katamine S. Cellular prion protein promotes Brucella infection into macrophages. J. Exp. Med. 198 (2003) 5-17
133. Sunyach C., Jen A., Deng J., Fitzgerald K.T., Frobert Y., Grassi J., McCaffrey M.W., and Morris R. The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J. 22 (2003) 3591-3601
134. Naroeni A., and Porte F. Role of cholesterol and the ganglioside GM(1) in entry and short-term survival of Brucella suis in murine macrophages. Infect. Immun. 70 (2002) 1640-1644
135. Pizarro-Cerda J., Meresse S., Parton R.G., van der Goot G., Sola-Landa A., Lopez-Goni I., Moreno E., and Gorvel J.P. Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes. Infect. Immun. 66 (1998) 5711-5724
136. Pizarro-Cerda J., Moreno E., Sanguedolce V., Mege J.L., and Gorvel J.P. Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments. Infect. Immun. 66 (1998) 2387-2392
137. Celli J., and Gorvel J.P. Organelle robbery: Brucella interactions with the endoplasmic reticulum. Curr. Opin. Microbiol. 7 (2004) 93-97
138. Porte F., Liautard J.P., and Kohler S. Early acidification of phagosomes containing Brucella suis is essential for intracellular survival in murine macrophages. Infect. Immun. 67 (1999) 4041-4047
139. Kagan J.C., and Roy C.R. Legionella phagosomes intercept vesicular traffic from endoplasmic reticulum exit sites. Nat. Cell Biol. 4 (2002) 945-954
140. Delrue R.M., Martinez-Lorenzo M., Lestrate P., Danese I., Bielarz V., Mertens P., De Bolle X., Tibor A., Gorvel J.P., and Letesson J.J. Identification of Brucella spp. genes involved in intracellular trafficking. Cell Microbiol. 3 (2001) 487-497
141. O'Callaghan D., Cazevieille C., Allardet-Servent A., Boschiroli M.L., Bourg G., Foulongne V., Frutos P., Kulakov Y., and Ramuz M. A homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suis. Mol. Microbiol. 33 (1999) 1210-1220
142. Rittig M.G., Alvarez-Martinez M.T., Porte F., Liautard J.P., and Rouot B. Intracellular survival of Brucella spp. in human monocytes involves conventional uptake but special phagosomes. Infect. Immun. 69 (2001) 3995-4006
143. Gross A., Bouaboula M., Casellas P., Liautard J.P., and Dornand J. Subversion and utilization of the host cell cyclic adenosine 5′-monophosphate/protein kinase A pathway by Brucella during macrophage infection. J. Immunol. 170 (2003) 5607-5614
144. Boschiroli M.L., Ouahrani-Bettache S., Foulongne V., Michaux-Charachon S., Bourg G., Allardet-Servent A., Cazevieille C., Liautard J.P., Ramuz M., and O'Callaghan D. The Brucella suis virB operon is induced intracellularly in macrophages. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 1544-1549
145. Check E. Gene therapy put on hold as third child develops cancer. Nature 433 (2005) 561
146. Hacein-Bey-Abina S., von Kalle C., Schmidt M., Le Deist F., Wulffraat N., McIntyre E., Radford I., Villeval J.L., Fraser C.C., Cavazzana-Calvo M., and Fischer A. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348 (2003) 255-256
147. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M.P., Wulffraat N., Leboulch P., Lim A., Osborne C.S., Pawliuk R., Morillon E., Sorensen R., Forster A., Fraser P., Cohen J.I., de Saint Basile G., Alexander I., Wintergerst U., Frebourg T., Aurias A., Stoppa-Lyonnet D., Romana S., Radford-Weiss I., Gross F., Valensi F., Delabesse E., Macintyre E., Sigaux F., Soulier J., Leiva L.E., Wissler M., Prinz C., Rabbitts T.H., Le Deist F., Fischer A., and Cavazzana-Calvo M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302 (2003) 415-419
148. Calos M.P. The potential of extrachromosomal replicating vectors for gene therapy. Trends Genet. 12 (1996) 463-466
149. Ryan R.M., Green J., and Lewis C.E. Use of bacteria in anti-cancer therapies. Bioessays 28 (2006) 84-94
150. Vassaux G., Nitcheu J., Jezzard S., and Lemoine N.R. Bacterial gene therapy strategies. J. Pathol. 208 (2006) 290-298
151. Agorio C., Schreiber F., Sheppard M., Mastroeni P., Fernandez M., Martinez M.A., and Chabalgoity J.A. Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma. J. Gene Med. 5 (2007) 5